“These studies demonstrate significant progress in the journey to increase survival rates for brain cancer patients, Cellworks Singula™ enables oncologists to deeply understand which therapies will be efficacious for individual GBM and LGG patients and to avoid prescribing ineffective therapies that waste precious time.”